Extended Use of Polyethyleneglycol3350 Laxative in Constipated Patients

PHASE4CompletedINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

December 31, 2004

Conditions
Constipation
Interventions
DRUG

polyethyleneglycol3350

Trial Locations (45)

20037

Washington D.C.

20707

Laurel

23294

Richmond

23454

Virginia Beach

23502

Norfolk

23606

Newport News

27609

Raleigh

27612

Raleigh

28401

Wilmington

29651

Greer

30067

Marietta

30328

Atlanta

33407

West Palm Beach

33461

Lake Worth

33702

St. Petersburg

33707

St. Petersburg

33770

Largo

34741

Kissimmee

34761

Ocoee

35128

Pell City

35216

Hoover

36693

Mobile

37620

Bristol

37660

Kingsport

38120

Memphis

43212

Columbus

45236

Cincinnati

45242

Cincinnati

60181

Oakbrook Terrace

61602

Peoria

63017

St Louis

66215

Overland Park

76135

Fort Worth

76904

San Angelo

78705

Austin

78745

Austin

84121

Salt Lake City

85013

Phoenix

85251

Scottsdale

85306

Glendale

85712

Tucson

92801

Anaheim

95825

Sacramento

01107

Springfield

08880

South Bound Brook

Sponsors
All Listed Sponsors
lead

Braintree Laboratories

INDUSTRY